China Healthcare Cold Chain Logistics Market Size and Share Analysis Report: Forecast Trends and Outlook (2025-2034)
Description
The China healthcare cold chain logistics market was valued at USD 3.66 Billion in 2024 and is expected to grow at a CAGR of 8.90% , reaching USD 8.59 Billion by 2034 . The expanding biopharmaceutical manufacturing, stringent quality regulations, and increased vaccine distribution are driving market growth, supported by infrastructure modernization and advanced temperature-controlled storage technologies.
Key Trends and Insights
The market is growing robustly due to the expanding pharmaceutical and biotechnology sectors. Rising vaccine production, temperature-sensitive biologics, and regulatory standards on product safety are fueling investments in cold chain infrastructure. Technological advancements in temperature monitoring and transportation systems enhance efficiency and reliability. Moreover, government initiatives supporting healthcare innovation and logistics modernization further strengthen the ecosystem, positioning China as a leading hub for secure and efficient healthcare cold chain distribution. The market is anticipated to grow at a CAGR of 8.90% during the forecast period of 2025-2034.
China Healthcare Cold Chain Logistics Market Growth Drivers
Expansion of Cold Chain Infrastructure Supporting Pharmaceutical Logistics Growth in China
The market is being driven by expanding cold storage infrastructure and regulatory support. In 2025, the Chinese government introduced subsidies to modernize pharmaceutical logistics networks, resulting in an 8% year-on-year increase in cold storage capacity. Growing demand for temperature-sensitive biologics, vaccines, and cell-based therapies has further boosted investments from key players like Cold Chain Technologies and DHL Supply Chain. This infrastructural expansion enhances temperature integrity, ensuring quality and safety in drug distribution across China’s rapidly growing biopharmaceutical sector.
China Healthcare Cold Chain Logistics Market Trends
Major market trends highlight China’s shift toward smart, sustainable, and technology-driven pharmaceutical logistics solutions.
Increasing Investments in Advanced Temperature-Control Technologies to Boost China Healthcare Cold Chain Logistics Market Demand
A significant trend in China’s cold chain logistics market is the adoption of advanced temperature-control systems and IoT-enabled monitoring. Companies are deploying real-time data tracking, predictive analytics, and reusable thermal packaging to ensure compliance with Good Distribution Practices (GDP). The 2025 expansion of Cold Chain Technologies’ APAC hubs, including China, reflects rising demand for energy-efficient, high-performance systems to support biologics and mRNA vaccines. This trend demonstrates China’s transition from conventional logistics to smart, sustainable, and precision-based pharmaceutical cold chain operations.
China Healthcare Cold Chain Logistics Market Share
Biopharmaceuticals to Lead the Segment by Product Type
The biopharmaceutical segment held the dominant position in the market, accounting for approximately 49% of total revenue during the historical period. This strong performance was driven by the surging demand for temperature-sensitive vaccines, biologics, and advanced therapeutics, coupled with expanding biopharmaceutical manufacturing capacities. Continuous advancements in cold storage infrastructure and logistics technology further supported the segment’s growth and reinforced its leading share in the overall market.
Leading Players in the China Healthcare Cold Chain Logistics Market
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Cardinal Health
Founded in 1971 and headquartered in Dublin, Ohio, USA, Cardinal Health is a global leader in healthcare distribution and logistics. The company offers advanced cold chain logistics solutions, ensuring the safe and compliant transport of temperature-sensitive pharmaceuticals and biologics. In China, Cardinal Health focuses on optimizing supply chain efficiency for biopharmaceutical companies through integrated distribution, regulatory compliance, and storage services tailored to the healthcare cold chain market.
DHL Group (DHL Supply Chain & GF)
Headquartered in Bonn, Germany, and established in 1969, DHL Group (DHL Supply Chain & Global Forwarding) is a leading global logistics provider specializing in healthcare cold chain management. The company offers end-to-end temperature-controlled logistics, warehousing, and last-mile delivery solutions across China. Its Life Sciences and Healthcare division supports pharmaceutical and biotechnology clients with certified facilities, real-time monitoring, and sustainable logistics operations.
UPS Healthcare
Founded in 1907 and headquartered in Atlanta, Georgia, USA, UPS Healthcare provides specialized cold chain logistics solutions designed for the biopharmaceutical and medical device industries. In China, UPS operates advanced temperature-controlled facilities and employs smart monitoring systems to ensure shipment integrity. Its portfolio includes cold storage, distribution, and express delivery services, enabling safe handling of critical healthcare products across the Chinese life sciences supply chain.
FedEx Logistics
Established in 1973 and based in Memphis, Tennessee, USA, FedEx Logistics delivers global cold chain transportation and supply chain management solutions for the healthcare industry. In China, it provides integrated cold storage, real-time tracking, and express shipping services tailored for pharmaceuticals, vaccines, and biologics. Through its FedEx Cold Chain Solutions, the company ensures temperature integrity and regulatory compliance throughout cross-border and domestic healthcare logistics operations.
Other players in the market include CEVA Logistics, Agility Logistics, Lineage Logistics, Nippon Express, SF Express, and AirBridgeCargo Airlines.
China Healthcare Cold Chain Logistics Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Service Type
Key Trends and Insights
- China contributed approximately 4.4% of the global healthcare cold chain logistics market revenue during the historical period.
- The biopharmaceutical segment dominated the market by product type, accounting for about 49% of total revenue in the historical period.
- By service type, storage is expected to lead the market in the forecast period.
- Market Size (2024): USD 3.66 Billion
- Projected Market Size (2034): USD 8.59 Billion
- CAGR (2025-2034): 8.90%
The market is growing robustly due to the expanding pharmaceutical and biotechnology sectors. Rising vaccine production, temperature-sensitive biologics, and regulatory standards on product safety are fueling investments in cold chain infrastructure. Technological advancements in temperature monitoring and transportation systems enhance efficiency and reliability. Moreover, government initiatives supporting healthcare innovation and logistics modernization further strengthen the ecosystem, positioning China as a leading hub for secure and efficient healthcare cold chain distribution. The market is anticipated to grow at a CAGR of 8.90% during the forecast period of 2025-2034.
China Healthcare Cold Chain Logistics Market Growth Drivers
Expansion of Cold Chain Infrastructure Supporting Pharmaceutical Logistics Growth in China
The market is being driven by expanding cold storage infrastructure and regulatory support. In 2025, the Chinese government introduced subsidies to modernize pharmaceutical logistics networks, resulting in an 8% year-on-year increase in cold storage capacity. Growing demand for temperature-sensitive biologics, vaccines, and cell-based therapies has further boosted investments from key players like Cold Chain Technologies and DHL Supply Chain. This infrastructural expansion enhances temperature integrity, ensuring quality and safety in drug distribution across China’s rapidly growing biopharmaceutical sector.
China Healthcare Cold Chain Logistics Market Trends
Major market trends highlight China’s shift toward smart, sustainable, and technology-driven pharmaceutical logistics solutions.
Increasing Investments in Advanced Temperature-Control Technologies to Boost China Healthcare Cold Chain Logistics Market Demand
A significant trend in China’s cold chain logistics market is the adoption of advanced temperature-control systems and IoT-enabled monitoring. Companies are deploying real-time data tracking, predictive analytics, and reusable thermal packaging to ensure compliance with Good Distribution Practices (GDP). The 2025 expansion of Cold Chain Technologies’ APAC hubs, including China, reflects rising demand for energy-efficient, high-performance systems to support biologics and mRNA vaccines. This trend demonstrates China’s transition from conventional logistics to smart, sustainable, and precision-based pharmaceutical cold chain operations.
China Healthcare Cold Chain Logistics Market Share
Biopharmaceuticals to Lead the Segment by Product Type
The biopharmaceutical segment held the dominant position in the market, accounting for approximately 49% of total revenue during the historical period. This strong performance was driven by the surging demand for temperature-sensitive vaccines, biologics, and advanced therapeutics, coupled with expanding biopharmaceutical manufacturing capacities. Continuous advancements in cold storage infrastructure and logistics technology further supported the segment’s growth and reinforced its leading share in the overall market.
Leading Players in the China Healthcare Cold Chain Logistics Market
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Cardinal Health
Founded in 1971 and headquartered in Dublin, Ohio, USA, Cardinal Health is a global leader in healthcare distribution and logistics. The company offers advanced cold chain logistics solutions, ensuring the safe and compliant transport of temperature-sensitive pharmaceuticals and biologics. In China, Cardinal Health focuses on optimizing supply chain efficiency for biopharmaceutical companies through integrated distribution, regulatory compliance, and storage services tailored to the healthcare cold chain market.
DHL Group (DHL Supply Chain & GF)
Headquartered in Bonn, Germany, and established in 1969, DHL Group (DHL Supply Chain & Global Forwarding) is a leading global logistics provider specializing in healthcare cold chain management. The company offers end-to-end temperature-controlled logistics, warehousing, and last-mile delivery solutions across China. Its Life Sciences and Healthcare division supports pharmaceutical and biotechnology clients with certified facilities, real-time monitoring, and sustainable logistics operations.
UPS Healthcare
Founded in 1907 and headquartered in Atlanta, Georgia, USA, UPS Healthcare provides specialized cold chain logistics solutions designed for the biopharmaceutical and medical device industries. In China, UPS operates advanced temperature-controlled facilities and employs smart monitoring systems to ensure shipment integrity. Its portfolio includes cold storage, distribution, and express delivery services, enabling safe handling of critical healthcare products across the Chinese life sciences supply chain.
FedEx Logistics
Established in 1973 and based in Memphis, Tennessee, USA, FedEx Logistics delivers global cold chain transportation and supply chain management solutions for the healthcare industry. In China, it provides integrated cold storage, real-time tracking, and express shipping services tailored for pharmaceuticals, vaccines, and biologics. Through its FedEx Cold Chain Solutions, the company ensures temperature integrity and regulatory compliance throughout cross-border and domestic healthcare logistics operations.
Other players in the market include CEVA Logistics, Agility Logistics, Lineage Logistics, Nippon Express, SF Express, and AirBridgeCargo Airlines.
China Healthcare Cold Chain Logistics Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Service Type
- Storage
- Transportation
- Packaging
- Monitoring and Data Logging
- Vaccines
- Biopharmaceuticals
- Cell and Gene Therapies
- Clinical Trial Materials
- Medical Devices and Diagnostics
- Controlled Ambient (15–25 °C)
- Refrigerated (2–8 °C)
- Frozen (-20 °C)
- Deep-Frozen (-80 °C)
- Cryogenic (<-150 °C)
- Air Freight
- Sea Freight
- Road Transport
- Rail Transport
- Pharmaceutical and Biotech Manufacturers
- Contract Research and Manufacturing Organizations
- Hospitals and Clinics
- Blood Banks and Transfusion Centers
- Diagnostic Labs
- What was the China healthcare cold chain logistics market value in 2024?
- What is the China healthcare cold chain logistics market forecast outlook for 2025-2034?
- What is the market breakup based on service type?
- What is the market breakup based on product type?
- What is the market breakup based on temperature range?
- What is the market breakup based on mode of transportation?
- What is the market breakup based on end user?
- What are the major factors aiding the China healthcare cold chain logistics market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major China healthcare cold chain logistics market trends?
- Which service type will lead the market segment?
- Which product type will lead the market segment?
- Which temperature range will lead the market segment?
- Which mode of transportation will lead the market segment?
- Which end user will lead the market segment?
- Who are the key players involved in the China healthcare cold chain logistics market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Table of Contents
200 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Healthcare Cold Chain Logistics Market Overview
- 3.1 Asia Pacific Healthcare Cold Chain Logistics Market Overview
- 3.1.1 Asia Pacific Healthcare Cold Chain Logistics Market Historical Value (2018-2024)
- 3.1.2 Asia Pacific Healthcare Cold Chain Logistics Market Forecast Value (2025-2034)
- 3.2 China Healthcare Cold Chain Logistics Market Overview
- 3.2.1 China Healthcare Cold Chain Logistics Market Historical Value (2018-2024)
- 3.2.2 China Healthcare Cold Chain Logistics Market Forecast Value (2025-2034)
- 4 China Healthcare Cold Chain Logistics Market Landscape
- 4.1 China Healthcare Cold Chain Logistics Market: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 China Healthcare Cold Chain Logistics Market: Service Landscape
- 4.2.1 Analysis by Service Type
- 4.2.2 Analysis by Product Type
- 4.2.3 Analysis by Temperature Range
- 4.2.4 Analysis by Mode of Transportation
- 5 China Healthcare Cold Chain Logistics Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 PESTEL Analysis
- 5.3.1 Political
- 5.3.2 Economic
- 5.3.3 Social
- 5.3.4 Technological
- 5.3.5 Legal
- 5.3.6 Environment
- 5.4 Porter’s Five Forces Model
- 5.4.1 Bargaining Power of Suppliers
- 5.4.2 Bargaining Power of Buyers
- 5.4.3 Threat of New Entrants
- 5.4.4 Threat of Substitutes
- 5.4.5 Degree of Rivalry
- 5.5 Key Demand Indicators
- 5.6 Key Price Indicators
- 5.7 Industry Events, Initiatives, and Trends
- 5.8 Value Chain Analysis
- 6 China Healthcare Cold Chain Logistics Market Segmentation (218-2034)
- 6.1 China Healthcare Cold Chain Logistics Market (2018-2034) by Service Type
- 6.1.1 Storage
- 6.1.2 Transportation
- 6.1.3 Packaging
- 6.1.4 Monitoring & Data Logging
- 6.2 China Healthcare Cold Chain Logistics Market (2018-2034) by Product Type
- 6.2.1 Vaccines
- 6.2.2 Biopharmaceuticals
- 6.2.3 Cell & Gene Therapies
- 6.2.4 Clinical Trial Materials
- 6.2.5 Medical Devices & Diagnostics
- 6.3 China Healthcare Cold Chain Logistics Market (2018-2034) by Temperature Range
- 6.3.1 Controlled Ambient (15–25 °C)
- 6.3.2 Refrigerated (2–8 °C)
- 6.3.3 Frozen (-20 °C)
- 6.3.4 Deep-Frozen (-80 °C)
- 6.3.5 Cryogenic (<-150 °C)
- 6.4 China Healthcare Cold Chain Logistics Market (2018-2034) by Mode of Transportation
- 6.4.1 Air Freight
- 6.4.2 Sea Freight
- 6.4.3 Road Transport
- 6.4.4 Rail Transport
- 6.5 China Healthcare Cold Chain Logistics Market (2018-2034) by End User
- 6.5.1 Pharmaceutical & Biotech Manufacturers
- 6.5.2 Contract Research & Manufacturing Organizations
- 6.5.3 Hospitals & Clinics
- 6.5.4 Blood Banks & Transfusion Centers
- 6.5.5 Diagnostic Labs
- 7 Regulatory Framework
- 8 Funding and Investment Analysis
- 8.1 Analysis by Funding Instances
- 8.2 Analysis by Type of Funding
- 8.3 Analysis by Funding Amount
- 8.4 Analysis by Leading Players
- 8.5 Analysis by Leading Investors
- 8.6 Analysis by Geography
- 9 Strategic Initiatives
- 9.1 Analysis by Partnership Instances
- 9.2 Analysis by Type of Initiatives
- 9.3 Analysis by Leading Players
- 9.4 Analysis by Geography
- 10 Supplier Landscape
- 10.1 Vendor Positioning Analysis
- 10.1.1 Key Vendors
- 10.1.2 Prospective Leaders
- 10.1.3 Niche Leaders
- 10.1.4 Disruptors
- 10.2 Market Share Analysis, By Country (Top 5 Companies)
- 10.3 Cardinal Health
- 10.3.1 Financial Analysis
- 10.3.2 Service Portfolio
- 10.3.3 Demographic Reach and Achievements
- 10.3.4 Company News and Developments
- 10.3.5 Certifications
- 10.4 DHL Group (DHL Supply Chain & GF)
- 10.4.1 Financial Analysis
- 10.4.2 Service Portfolio
- 10.4.3 Demographic Reach and Achievements
- 10.4.4 Company News and Developments
- 10.4.5 Certifications
- 10.5 UPS Healthcare
- 10.5.1 Financial Analysis
- 10.5.2 Service Portfolio
- 10.5.3 Demographic Reach and Achievements
- 10.5.4 Company News and Developments
- 10.5.5 Certifications
- 10.6 FedEx Logistics
- 10.6.1 Financial Analysis
- 10.6.2 Service Portfolio
- 10.6.3 Demographic Reach and Achievements
- 10.6.4 Company News and Developments
- 10.6.5 Certifications
- 10.7 CEVA Logistics
- 10.7.1 Financial Analysis
- 10.7.2 Service Portfolio
- 10.7.3 Demographic Reach and Achievements
- 10.7.4 Company News and Developments
- 10.7.5 Certifications
- 10.8 Agility Logistics
- 10.8.1 Financial Analysis
- 10.8.2 Service Portfolio
- 10.8.3 Demographic Reach and Achievements
- 10.8.4 Company News and Developments
- 10.8.5 Certifications
- 10.9 Lineage Logistics
- 10.9.1 Financial Analysis
- 10.9.2 Service Portfolio
- 10.9.3 Demographic Reach and Achievements
- 10.9.4 Company News and Developments
- 10.9.5 Certifications
- 10.10 Nippon Express
- 10.10.1 Financial Analysis
- 10.10.2 Service Portfolio
- 10.10.3 Demographic Reach and Achievements
- 10.10.4 Company News and Developments
- 10.10.5 Certifications
- 10.11 SF Express
- 10.11.1 Financial Analysis
- 10.11.2 Service Portfolio
- 10.11.3 Demographic Reach and Achievements
- 10.11.4 Company News and Developments
- 10.11.5 Certifications
- 10.12 AirBridgeCargo Airlines
- 10.12.1 Financial Analysis
- 10.12.2 Service Portfolio
- 10.12.3 Demographic Reach and Achievements
- 10.12.4 Company News and Developments
- 10.12.5 Certifications
- 11 China Healthcare Cold Chain Logistics Market – Distribution Model (Additional Insight)
- 11.1 Overview
- 11.2 Potential Distributors
- 11.3 Key Parameters for Distribution Partner Assessment
- 12 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
